This is a line-in-the-sand moment for legal cannabis. In this episode of Higher Exchanges, Jesse Redmond and Morgan Paxhia break down the Schedule III announcement alongside policy expert Hirsh Jain and capital markets veteran Scott Grossman. We unpack what just happened, why it matters, and what could come next for cannabis policy and markets. We cover: • A clear overview of the Schedule III news and first reactions • What changes on the policy side — including CBD and Medicare...
All content for Higher Exchanges is the property of Higher Exchanges and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
This is a line-in-the-sand moment for legal cannabis. In this episode of Higher Exchanges, Jesse Redmond and Morgan Paxhia break down the Schedule III announcement alongside policy expert Hirsh Jain and capital markets veteran Scott Grossman. We unpack what just happened, why it matters, and what could come next for cannabis policy and markets. We cover: • A clear overview of the Schedule III news and first reactions • What changes on the policy side — including CBD and Medicare...
The Global Playbook with Zachary George, CEO of SNDL
Higher Exchanges
1 hour 13 minutes
7 months ago
The Global Playbook with Zachary George, CEO of SNDL
Zachary George joins Higher Exchanges to share the strategic vision behind SNDL’s transformation into a debt-free, cash-rich cannabis leader. We cover: 🌱 Zach’s journey from Wall Street to cannabis 🇨🇦 Canada's retail evolution & market reset 🌍 Germany & global growth opportunities 🇺🇸 U.S. expansion strategy & OTC ambitions 💰 Capital deployment: buybacks, M&A, and long-term ROI Plus, another fun question for Grok.
Higher Exchanges
This is a line-in-the-sand moment for legal cannabis. In this episode of Higher Exchanges, Jesse Redmond and Morgan Paxhia break down the Schedule III announcement alongside policy expert Hirsh Jain and capital markets veteran Scott Grossman. We unpack what just happened, why it matters, and what could come next for cannabis policy and markets. We cover: • A clear overview of the Schedule III news and first reactions • What changes on the policy side — including CBD and Medicare...
